Last reviewed · How we verify
NCT06766396
Predictors of PPIUCD Discontinuation at Two Years: A Clinical Study in Pakistan
NA trial testing Postpartum Intrauterine Contraceptive Device (PPIUCD). in Postpartum Contraception in 3,400 participants. Completed in 31 December 2022.
31 December 2022
Quick facts
| Lead sponsor | Services Institute of Medical Sciences, Pakistan |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 3,400 |
| Start date | 1 November 2017 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 December 2022 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Postpartum Intrauterine Contraceptive Device (PPIUCD).
Conditions studied
- Postpartum Contraception — all drugs for Postpartum Contraception →
- Reproductive Health — all drugs for Reproductive Health →
- Family Planning — all drugs for Family Planning →
Sponsor
Services Institute of Medical Sciences, Pakistan
Who can join
Eligibility, female only, with Postpartum Contraception or Reproductive Health. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This prospective cohort study evaluated the continuation rates, complications, and satisfaction associated with postpartum intrauterine contraceptive devices (PPIUCDs) as a long-acting reversible contraception (LARC) method. Conducted in the Department of Obstetrics and Gynecology at Services Hospital, Lahore, Pakistan, from November 2017 to December 31, 2022, the study enrolled pregnant women attending antenatal care. Counseling was conducted using the GATHER technique, and informed consent was obtained before insertion. PPIUCDs were inserted postpartum during vaginal or cesarean deliveries by trained healthcare professionals. Follow-ups at 3, 6, 12, and 24 months assessed continuation rates, complications, and reasons for discontinuation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06766396
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Services Institute of Medical Sciences, Pakistan trials
Trials by the same sponsor.
- NCT07274319 — EFFICACY OF TRANSMUCOSAL MINIPLEITE STABILIZATION TECHNIQUE VERSUS INTRA-ARCH WIRE STABILIZATION TECHNIQUE FOR FIXATION · NA · not yet recruiting
- NCT07238946 — Musculoskeletal Pain and Its Association With Stress in Medical Students · completed
- NCT06720051 — Intraosseous Versus Submucosal Dexamethsone Injection in Third Molar Surgery · NA · not yet recruiting
- NCT07243977 — Comparison of Microneedling Along With Topical Vitamin D3 Versus Microneedling in Alopecia Areata · NA · active not recruiting
- NCT06622642 — Efficacy of Transoral Versus Transbuccal Technique for Fixation of Mandibular Angle Fracture · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06766396 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Services Institute of Medical Sciences, Pakistan
- Last refreshed: 9 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06766396.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing